How does COVID-19 affect the outcomes of patients with acute myeloid leukemia?

During the EHA2021 Virtual Congress, Know AML spoke with Olga Gavrilina, National Research Center for Hematology, Moscow, RU. We asked, How does COVID-19 affect the outcomes of patients with acute myeloid leukemia? In this video, Gavrilina discusses the complications, therapy options, prognosis, vaccination, and the possibility of reinfection for patients diagnosed with acute myeloid leukemia and COVID-19 infection.

All content on Know AML is primarily intended for patients and caregivers. If you are a healthcare professional, please visit the AML Hub.

Please get in touch if you have any questions about Know AML or if you would like to discuss a potential collaboration.

Brought to you by

Scientific Education Support

In collaboration with

Thank you to the funders of Know AML. All content is developed independently by SES in collaboration with an expert ambassador group; funders are allowed no influence on the content of Know AML.

v2.29.00